
Researchers from Denmark and the USA have created an innovative artificial intelligence-based platform that could herald the beginning of a new era in treating cancer. The new approach can significantly speed up the process of designing personalized therapy for cancer patients, according to Science. The algorithm forms a protein “mini-blocker” that tightly binds to a selected tumor target. Samara Online 24 Scientists suggest that clinical trials could begin in about five years; in the future, there might be repositories of already tested proteins for various tumors, reports sciencexxi.com.